Current Environment: Production

Elena Crestani | Education

Medical School

University of Verona

2000, Verona, Italy

Graduate School

University of Texas Health Science Center

2006, Houston, TX

Residency

University of Texas Health Science Center

2011, Houston, TX

Fellowship

Boston Children's Hospital

2015, Boston, MA

Elena Crestani | Certifications

  • American Board of Allergy & Immunology (General)
  • American Board of Pediatrics (General)

Elena Crestani | Publications

  1. RELMß sets the threshold for microbiome-dependent oral tolerance. Nature. 2025 Feb; 638(8051):760-768. View RELMß sets the threshold for microbiome-dependent oral tolerance. Abstract

  2. Notch4 regulatory T cells and SARS-CoV-2 viremia shape COVID19 survival outcome. Allergy. 2025 Feb; 80(2):557-569. View Notch4 regulatory T cells and SARS-CoV-2 viremia shape COVID19 survival outcome. Abstract

  3. An Atypical Case of Parotid Swelling. Pediatr Rev. 2024 Sep 01; 45(9):535-539. View An Atypical Case of Parotid Swelling. Abstract

  4. Age-specific Metabolomic profiles in children with food allergy. Clin Immunol. 2024 04; 261:109928. View Age-specific Metabolomic profiles in children with food allergy. Abstract

  5. Piloting a multidisciplinary group education session to support caregivers of children with food protein-induced enterocolitis syndrome (FPIES). J Allergy Clin Immunol Pract. 2023 Oct; 11(10):3260-3262.e1. View Piloting a multidisciplinary group education session to support caregivers of children with food protein-induced enterocolitis syndrome (FPIES). Abstract

  6. The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children. J Clin Invest. 2023 01 03; 133(1). View The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children. Abstract

  7. SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children. Clin Immunol. 2022 Oct; 243:109106. View SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children. Abstract

  8. A common IL-4 receptor variant promotes asthma severity via a Treg cell GRB2-IL-6-Notch4 circuit. Allergy. 2022 11; 77(11):3377-3387. View A common IL-4 receptor variant promotes asthma severity via a Treg cell GRB2-IL-6-Notch4 circuit. Abstract

  9. Atopic Dermatitis Mediates the Association Between an IL4RA Variant and Food Allergy in School-Aged Children. J Allergy Clin Immunol Pract. 2022 08; 10(8):2117-2124.e4. View Atopic Dermatitis Mediates the Association Between an IL4RA Variant and Food Allergy in School-Aged Children. Abstract

  10. Notch1-CD22-Dependent Immune Dysregulation in the SARS-CoV2-Associated Multisystem Inflammatory Syndrome in Children. Res Sq. 2022 Apr 11. View Notch1-CD22-Dependent Immune Dysregulation in the SARS-CoV2-Associated Multisystem Inflammatory Syndrome in Children. Abstract

  11. A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface. Proc Natl Acad Sci U S A. 2022 01 04; 119(1). View A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface. Abstract

  12. Author Correction: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2021 Jun; 22(6):794-795. View Author Correction: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Abstract

  13. Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections. Immunity. 2021 06 08; 54(6):1186-1199.e7. View Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections. Abstract

  14. Author Correction: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2021 Jan; 22(1):100. View Author Correction: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Abstract

  15. Regulatory T Cell-Derived TGF-ß1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity. Immunity. 2020 Dec 15; 53(6):1331-1332. View Regulatory T Cell-Derived TGF-ß1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity. Abstract

  16. Regulatory T Cell-Derived TGF-ß1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity. Immunity. 2020 12 15; 53(6):1202-1214.e6. View Regulatory T Cell-Derived TGF-ß1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity. Abstract

  17. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. J Allergy Clin Immunol Pract. 2020 10; 8(9S):S16-S116. View Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. Abstract

  18. A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2020 11; 21(11):1359-1370. View A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Abstract

  19. Dietary and Microbial Determinants in Food Allergy. Immunity. 2020 08 18; 53(2):277-289. View Dietary and Microbial Determinants in Food Allergy. Abstract

  20. Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma. J Allergy Clin Immunol. 2020 03; 145(3):897-906. View Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma. Abstract

  21. Author Correction: Microbiota therapy acts via a regulatory T cell MyD88/ROR?t pathway to suppress food allergy. Nat Med. 2019 Sep; 25(9):1458. View Author Correction: Microbiota therapy acts via a regulatory T cell MyD88/ROR?t pathway to suppress food allergy. Abstract

  22. Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis. Am J Hum Genet. 2019 09 05; 105(3):549-561. View Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis. Abstract

  23. Microbiota therapy acts via a regulatory T cell MyD88/ROR?t pathway to suppress food allergy. Nat Med. 2019 07; 25(7):1164-1174. View Microbiota therapy acts via a regulatory T cell MyD88/ROR?t pathway to suppress food allergy. Abstract

  24. Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose Adjustment. J Allergy Clin Immunol Pract. 2018 Sep - Oct; 6(5):1711-1716.e4. View Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose Adjustment. Abstract

  25. Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):476-485.e3. View Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. Abstract

  26. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016 10 17; 213(11):2413-2435. View Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. Abstract

  27. Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly. J Allergy Clin Immunol. 2016 Jan; 137(1):324-327.e2. View Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly. Abstract

  28. Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia. J Allergy Clin Immunol. 2015 Nov; 136(5):1401-4.e1-3. View Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Abstract

  29. RAG1 deficiency may present clinically as selective IgA deficiency. J Clin Immunol. 2015 Apr; 35(3):280-8. View RAG1 deficiency may present clinically as selective IgA deficiency. Abstract

  30. IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient. Pediatr Allergy Immunol. 2014 Dec; 25(8):821-3. View IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient. Abstract

  31. RAG1 reversion mosaicism in a patient with Omenn syndrome. J Clin Immunol. 2014 Jul; 34(5):551-4. View RAG1 reversion mosaicism in a patient with Omenn syndrome. Abstract

  32. Association of IL-5 cytokine production and in vivo IgE levels in infants and parents. J Allergy Clin Immunol. 2007 Oct; 120(4):820-6. View Association of IL-5 cytokine production and in vivo IgE levels in infants and parents. Abstract

  33. Exhaled air temperature in asthma: methods and relationship with markers of disease. Clin Exp Allergy. 2007 Mar; 37(3):415-9. View Exhaled air temperature in asthma: methods and relationship with markers of disease. Abstract

  34. Parental asthma as a risk factor for the development of early skin test sensitization in children. J Allergy Clin Immunol. 2004 Feb; 113(2):284-90. View Parental asthma as a risk factor for the development of early skin test sensitization in children. Abstract

  35. Fractionated total body irradiation in bone marrow transplantation--an emphasis on lung dosimetry. Australas Radiol. 1983 Jul; 27(2):186-94. View Fractionated total body irradiation in bone marrow transplantation--an emphasis on lung dosimetry. Abstract

BESbswy
BESbswy